Cingulate Inc. vs Kyntra Bio, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Cingulate Inc. and Kyntra Bio, Inc. are worth about the same: $83 M and $79 M (market caps of Oct 28, 2026 for Cingulate Inc. and Jan 5, 2024 for Kyntra Bio, Inc.). Kyntra Bio, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Kyntra Bio, Inc. made a net profit of $183 M, while Cingulate Inc. made a net loss of $22 M.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Cingulate Inc. CING · #19,432 in the world | Kyntra Bio, Inc. KYNB |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $83 M | $79 M* |
| Revenue | — | $6 M |
| Net income | $-22 M | $183 M▲ best |
| Employees | — | 566 |
| Valuation | ||
| Price to book | 33.0× | — |
| Free cash flow yield | -21.0% | — |
| Profitability | ||
| Gross margin | — | 91.3% |
| Operating margin | — | -712.7% |
| Return on equity | -450.4% | — |
| Growth | ||
| Revenue growth | — | -78.3% |
| Revenue growth, 3 years a year | — | -64.2% |
| Financial strength | ||
| Interest cover | -22.2× | -5.2×▲ best |
| Cash | ||
| Free cash flow margin | — | -74.7% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024; ratios FY2025 |
Questions and answers#
Which is bigger, Cingulate Inc. or Kyntra Bio, Inc.?
Cingulate Inc. and Kyntra Bio, Inc. are worth about the same: $83 M and $79 M (market caps of Oct 28, 2026 for Cingulate Inc. and Jan 5, 2024 for Kyntra Bio, Inc.). Kyntra Bio, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Cingulate Inc. or Kyntra Bio, Inc.?
Kyntra Bio, Inc. made a net profit of $183 M, while Cingulate Inc. made a net loss of $22 M.